Han X, Wang X, Yan J, Song P, Wang Y, Kang Y
Mater Today Bio. 2025; 30():101429.
PMID: 39839492
PMC: 11750283.
DOI: 10.1016/j.mtbio.2024.101429.
Cui X, Song Y, Han J, Yuan Z
Biochem Biophys Rep. 2025; 41():101902.
PMID: 39802394
PMC: 11721226.
DOI: 10.1016/j.bbrep.2024.101902.
Bosteels V, Janssens S
Nat Rev Immunol. 2024; 25(2):125-140.
PMID: 39289483
DOI: 10.1038/s41577-024-01079-5.
Nakano T, Goto S, Chen C
Int J Mol Sci. 2024; 25(17).
PMID: 39273280
PMC: 11395488.
DOI: 10.3390/ijms25179331.
Pelissier A, Laragione T, Gulko P, Rodriguez Martinez M
Front Immunol. 2024; 15:1428773.
PMID: 39161769
PMC: 11330812.
DOI: 10.3389/fimmu.2024.1428773.
Clara cell 10 (CC10) protein attenuates allergic airway inflammation by modulating lung dendritic cell functions.
Xu Y, Cheng M, Mao J, Zhang X, Shang P, Long J
Cell Mol Life Sci. 2024; 81(1):321.
PMID: 39078462
PMC: 11335244.
DOI: 10.1007/s00018-024-05368-z.
Nuclear squeezing wakes up dendritic cells.
Lembo S, Sixt M
Nat Immunol. 2024; 25(7):1131-1132.
PMID: 38907047
DOI: 10.1038/s41590-024-01881-2.
Mechanism of Action of Oral -Based Vaccine to Prevent and Reverse Type 1 Diabetes in NOD Mice.
Cobb J, Rawson J, Gonzalez N, Singer M, Kandeel F, Husseiny M
Vaccines (Basel). 2024; 12(3).
PMID: 38543910
PMC: 10975319.
DOI: 10.3390/vaccines12030276.
Dendritic Cells as a Therapeutic Strategy in Acute Myeloid Leukemia: Vaccines.
Palomares F, Pina A, Dakhaoui H, Leiva-Castro C, Munera-Rodriguez A, Cejudo-Guillen M
Vaccines (Basel). 2024; 12(2).
PMID: 38400148
PMC: 10891551.
DOI: 10.3390/vaccines12020165.
Durable protective efficiency provide by mRNA vaccines require robust immune memory to antigens and weak immune memory to lipid nanoparticles.
Tang X, Zhang J, Sui D, Xu Z, Yang Q, Wang T
Mater Today Bio. 2024; 25:100988.
PMID: 38379935
PMC: 10877184.
DOI: 10.1016/j.mtbio.2024.100988.
PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice.
Frijlink E, Bosma D, Bosma D, Busselaar J, Battaglia T, Staal M
J Clin Invest. 2024; 134(6).
PMID: 38349740
PMC: 10940086.
DOI: 10.1172/JCI171154.
Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.
Paris-Munoz A, Leon-Triana O, Perez-Martinez A, Barber D
Int J Mol Sci. 2024; 25(1).
PMID: 38203623
PMC: 10778776.
DOI: 10.3390/ijms25010452.
Therapeutic induction of antigen-specific immune tolerance.
Kenison J, Stevens N, Quintana F
Nat Rev Immunol. 2023; 24(5):338-357.
PMID: 38086932
PMC: 11145724.
DOI: 10.1038/s41577-023-00970-x.
Notch Signaling Regulates the Function and Phenotype of Dendritic Cells in Infection.
Liu Q, Chen C, He Y, Mai W, Ruan S, Ning Y
Microorganisms. 2023; 11(11).
PMID: 38004829
PMC: 10673485.
DOI: 10.3390/microorganisms11112818.
Tolerogenic dendritic cells generated using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance.
Dao Nyesiga G, Pool L, Englezou P, Hylander T, Ohlsson L, Appelgren D
Front Immunol. 2023; 14:1045183.
PMID: 37901231
PMC: 10613069.
DOI: 10.3389/fimmu.2023.1045183.
Dendritic cells in liver transplantation immune response.
Du X, Li M, Huan C, Lv G
Front Cell Dev Biol. 2023; 11:1277743.
PMID: 37900282
PMC: 10606587.
DOI: 10.3389/fcell.2023.1277743.
Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics.
Papadakos S, Arvanitakis K, Stergiou I, Vallilas C, Sougioultzis S, Germanidis G
Pharmaceutics. 2023; 15(10).
PMID: 37896221
PMC: 10610499.
DOI: 10.3390/pharmaceutics15102460.
A L. Non-Polar Extract Modulates the Polarization of Human Macrophages and Dendritic Cells into an Anti-Inflammatory Phenotype.
Rodriguez Mesa X, Contreras Bolanos L, Costa G, Mejia A, Santander Gonzalez S
Molecules. 2023; 28(20).
PMID: 37894572
PMC: 10608814.
DOI: 10.3390/molecules28207094.
Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming.
Liu X, Yu P, Xu Y, Wang Y, Chen J, Tang F
Cell Mol Life Sci. 2023; 80(10):283.
PMID: 37688662
PMC: 10492886.
DOI: 10.1007/s00018-023-04932-3.
CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells.
Zhang Y, Hu J, Ji K, Jiang S, Dong Y, Sun L
Cell Rep Med. 2023; 4(8):101151.
PMID: 37567173
PMC: 10439278.
DOI: 10.1016/j.xcrm.2023.101151.